What's new. News and updates from Ali Ramezani
Recent publications, conference talks, patent filings, and project milestones from the lab and the Nephrova and Medistant programs.
Diffusion-correction paper published in Scientific Reports
“Correcting Diffusion Artifacts in Urinary Oxygen Tension Monitoring” restores the diagnostic value of bedside urinary PO₂ by removing oxygen-diffusion artifacts.
Named an MIT Catalyst Fellow
Selected for MIT’s translational research program advancing high-impact healthcare technologies from concept toward clinical and commercial viability.
International PCT application filed for fluid transit-time tracking
“System and Method for Tracking Fluid Transit Time in a Conduit” (WO2026060269A1) extends the urinary-oxygen monitoring program toward commercial translation.
U.S. provisional patent filed: “Diffusion Adjusted Sensor System and Method”
Protecting the diffusion-correction method behind more trustworthy bedside urinary-oxygen monitoring.
Transit-time algorithm paper published in the Journal of Clinical Monitoring and Computing
An algorithm establishing sample validity so a bedside oxygen reading reflects the kidney rather than the tubing.